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The systemic administration of anfiviral serum has been shown to 
be  beneficial  as  a  prophylactic measure  in  certain  virus  diseases, 
notably measles.  It has proved difficult, however, to  establish ex- 
perimentally a  general passive immunity against others, particularly 
in larger hosts and against viruses which invade the central nervous 
system by  way  of peripheral  neural  routes  (1,  2).  Protection  of 
selected skin sites by the local injection of immune serum prior to the 
inoculation of certain dermotropic viruses has been demonstrated by 
several investigators (3-5).  This local protection or passive immu- 
nity of the skin persisted for several days and in the case of pantropic, 
neuroinvasive  viruses,  such  as  pseudorabies  and  B  virus,  it  was 
found that not only was the skin lesion prevented but also invasion 
of the central nervous system (6). 
Since the nasal  route is  considered to  be the portal of entry for 
many virus infections, it was  deemed advisable  to  investigate the 
possibilities and limitations of local prophylaxis by means of specific 
antiviral serum.  If the method of local protection in the skin were 
followed, it would be necessary to intiitrate the entire nasal mucosa 
with  immune serum,  which  dearly  is  not  practical.  It  has  been 
observed, however, that minced susceptible tissue upon contact with 
antiviral serum was  capable of fixing protective substance to  such 
an extent that upon removal of the tissue from the serum and even 
after one or two washings it would remain refractory to infection with 
virus in in vitro  cultures  (5).  It appeared possible, therefore, that 
* Work begun at the Lister Institute, London, during the tenure of a National 
Research Council Fellowship in Medicine for 1934, and completed at The Rocke- 
feller Institute. 
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the cells of the nasal mucosa might respond in a similar manner when 
flushed with antiviral  serum. 
EXPERTM~NTAL 
The  virus  of  pseudorabies  (Aujeszky's  disease,  infectious  bulbar 
paralysis, mad itch) was selected for most of the experiments because 
its properties rendered it particularly  suitable for this type of inves- 
tigation.  It  produces  a  rapidly  fatal  (2  to  4  days)  encephalitis  in 
guinea  pigs,  following a  single  nasal  instillation  of minute  amounts 
of virus.  This  virus  invades  the  blood stream  and  viscera  as well 
as the central  nervous system and,  as shown  by  Hurst  (7a,  7b),  in 
rabbits it reaches the central  nervous system by way of the periph- 
eral nerves.  As a  result of its almost constant and rapid destructive 
effect on the sensory ganglion cells which are first attacked, the sites, 
which  the  infected  animals  scratch  or  bite,  serve  to  indicate  the 
nerves along which  the virus,  in all probability, reached  the  central 
nervous  system  from  the  periphery  (7a).  Guinea pigs infected in- 
tranasally  scratch  along  the  nose,  the  eyes,  the  ears,  or  the  jaw. 
This "marking or indicating"  property of the virus appeared particu- 
larly useful for these experiments, since it would tend to show whether 
in  treated  animals  encephalitis  was  induced  by way of  the  nerves 
from the nose, or whether the virt~s had gotten through the possibly 
protected region  of the nose into  the blood stream  and  reached  the 
central  nervous system by way of the nerves supplying  the viscera. 
It has already been shown that while pseudorabies antiviral serum 
mixed  with  virus  in  vitro  has  no  protective  effect  even  against 
minimal  doses when  injected intracerebrally  in  guinea  pigs,  it does 
prevent  infection  when  administered  by  the  nasal  route  (6).  It 
remained  to  be  determined,  therefore,  whether  immune  serum  in- 
stilled in the nose prior  to  the administration  of virus by this route 
would exert a  protective effect. 
The pseudorabies  virus  (Aujeszky strain)  was always used in  the form of 
fresh or glycerolated rabbit brain,  obtained  after intracerebral  injection of the 
virus.  Swine  antipseudorabies serum 1 was used in most of the experiments.  In 
preliminary  tests 0.25 cc.  of antiviral  serum  or of  normal  swine serum  was 
dropped into each nostril,  and an hour or two later,  0.25 cc. of a  10 per cent 
1 Kindly supplied by Dr. R. E. Shope. ALBERT B.  SABm  865 
centrifuged suspension of rabbit brain virus was instilled in each nostril.  All 
of the guinea pigs treated with normal swine serum died, while an occasional one 
of  those  treated  with  immune serum  survived.  It appeared,  however,  that 
better results might perhaps be obtained by increasing the amount of immune 
serum to  be instilled  and  diminishing  the  volume of  the  infective dose  to  a 
minimum in order to prevent it from getting into the lungs and to approximate 
natural conditions of infection by this route.  The serum was increased to 0.5 cc. 
per nostril, administered slowly from a blunt, smooth edged, glass pipette, and 
the virus was reduced to 0.05 cc. for each nostril--an amount still larger than 
that ordinarily transmitted by natural droplet infection.  A dose of 0.05 cc. per 
nostril of a 0.1 per cent virus suspension killed about half the number of control 
guinea pigs, while with the same amount of a 1 or 2 per cent suspension, only an 
occasional one survived.  In view of variations encountered with different virus 
preparations, each experiment necessarily had its own controls, and 1 per cent 
virus suspension was used when made with fresh brain and 2 per cent or 5 per 
cent with glycerolated tissue. 
Effect  of  Intranasal  and  Intramuscular  Administration  of  Anti- 
pseudorabies  Serum.--The  purpose  of  this  experiment  was  (a)  to 
determine whether the nasal instillation of immune serum would pro- 
tect  against  a  small,  yet  ordinarily  fatal,  amount  of  pseudorabies 
virus introduced  in  the nose 2  hours later;  (b)  to determine whether 
an immune serum homologous for the test animal, i,e.,  guinea pig in 
this case, might be more effective than the heterologous swine serum, 
and (c) to determine, in part at least, whether the effect of the nasally 
instilled  serum  is  local,  or  remote  after  absorption,  by  comparing 
it  with  that  produced  by  the  intramuscular  injection  of  an  even 
larger amount of  immune serum. 
Sixteen guinea pigs were divided into four groups.  One was untreated; the 
animals  of  the  second  group  each  received  3  cc. of  swine  antipseudorabies 
serum intramuscularly, while those of the third group were given 0.5  cc.  of the 
same serum in each nostril; the guinea pigs of the fourth group received 0.5  cc. 
in each nostril of guinea pig antipseudorabies serum.*  2 hours later all animals 
were instilled in each nostril with 0.05 cc. of a 2 per cent virus suspension. 
The  results  are  shown  in  TaMe  I.  All  the  guinea  pigs which  re- 
ceived the immune serum intranasally survived without showing any 
signs  of  disease,  while  all  those  which  were  given  the  serum  intra- 
muscularly  and  three  of  the  four  untreated  ones  died  with  typical 
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signs of pseudorabies on the 3rd day after inoculation.  This :experi- 
ment indicates that  (a)  immune serum, either homologous or heter- 
ologous as regards the host, instilled into the nose, is capable of pro- 
tecting the host for a period of at least 2 hours against invasion with 
TABLE  I 
Comparative  Effect  of  Intranasal  and  Intramuscular  Administration  of  Anti- 
pseudorables Serum on Susceptibility  of Guinea Pigs to Infection by the Nasal 
Route 
Type of antlpseudorabies 
set tun* 
Guinea pig 
Swine 
Untreated controls 
Amount  and route 
0.5 cc. in each nostril 
3 cc. intramuscularly 
Guinea p~  R~ult 
No. 
i  st 
2  S 
3  S 
4  S 
5  S 
6  S 
7  S 
8  S 
9  D~ 
1-0  Da 
1-1  Da 
1-2  D8 
1-3  D8 
1-4  Da 
1-5  Da 
1-6  S 
All guinea pigs were given 0.05  cc. of a  2 per cent virus suspension in each 
nostril. 
* Serum given 2 hours before virus. 
t  S  =  survived without showing signs of disease. 
:~ D3  =  died on 3rd day after inoculation, with evidence of scratching some 
part of the head. 
pseudorabies by way of the nose, and  (b) in view of the fact that the 
intramuscular  injection  of  an  even larger  amount  of immune  serum 
(about 1 cc. per 100 gm.) failed to prevent infection, the action of the 
nasally  instilled  serum was  necessarily  a  local  one.  The  possibility 
of greater absorption of a  diffusible agent into the cerebrospinal fluid ALBERT  B.  SABIN  867 
from the nose  than  from muscle is not significant,  because  immune 
serum,  even  when  mixed  with  pseudorabies  virus  in vitro, appears 
to  be incapable of preventing  infection when the mixture is injected 
intracerebrally in guinea pigs (6).  In view of the fact that pseudora- 
bies can spread  in  the  body  by routes  other  than  the  neural,  it  is 
interesting  to  observe  that protection  of  the "first line"  of cells to 
be attacked apparently also acts as a barrier to the further dissemina- 
tion of the virus to other parts  of the body where the cells are fully 
susceptible. 
It  may  be  said  by some  that  the  virus  is  "neutralized"  by  the 
immune  serum,  which obviously must remain  adherent to the nasal 
mucosa, and for that reason is inactive wherever it may spread.  But 
previous experiments  on  the mechanism  of the neutralizing  or pro- 
tective  action  of  antipseudorabies  serum  (5,  8)  which  showed  no 
evidence  of  union  between  the  virus  and  the  protective  antibody 
during  the  consummation  of the  immune  process,  make  it  difficult 
to  accept  this  explanation.  The  experiments  just  referred  to  (5) 
also indicated  that  susceptible cells rendered  refractory in  the pres- 
ence of immune  serum are capable of fixing virus apparently  to  the 
same extent as normal cells, but that the virus fixed to such refractory 
cells fails  to  multiply  and  becomes inactive  at  a  rate  which  varies 
with different viruses at  body temperature  under  conditions unfav- 
orable to multiplication.  On this basis, one can imagine how a super- 
ficial layer of protected cells may act as a barrier to deeper dissemina- 
tion of the virus, provided the dose is not too large, without resorting 
to a  concept of direct "neutralization." 
Duration of Protective Action of Immune Serum in the Nose and Effect 
of Certain Chemical Substances.-- 
To  determine  the  duration  of  the  protective  effect  of  nasally  instilled 
immune serum, three  groups of four guinea pigs were treated with  0.5  cc.  of 
swine antipseudorabies  serum in each nostril.  One group received the serum 
24 hours  before,  another  5  hours  before,  and  the  third,  2  hours  before  the 
time when they were all given 0.05 cc. of a 2 per cent virus suspension in each 
nostril.  Four guinea pigs were treated with  1 per cent tannic  acid  (0.5 co. in 
each nostril)  to determine  the effect of a single treatment with an astringent, 
protein-precipitating  substance (9).  0.1 per cent neutral acriflavine was used in 
a similar manner in another four guinea pigs; this chemical has been reported by 
Craigie and Tulloch  (10) as capable of rendering the rabbit skin refractory  to 868  PROTECTIVE  ACTION OF  SERUM AGAINST VIRUSES 
infection with vaccinia virus.  The neutral acriflavine by itself was shown by 
them not to be virucidal, as evidenced by the fact that upon dilution of such an 
inactive mixture to a point at which the concentration of acriflavine became too 
dilute to be effective, they obtained a suspension which was again infective.  The 
TABLE  II 
Duration of Local Protective Action of A ntipseudorabies Serum When Administered 
by the Nasal Route and Effect of Certain Chemicals 
Interval between 
Treatment  treatment and  Guinea pig No.  Result 
virus 
Antipseudorabies swine serum 0.5 
cc. in each nostril 
4.a 
L) 
1% tannic acid 0.5 cc. in 
each nostril 
0.1%  neutral  acriflavine 
0.5 cc. in each nostril 
None 
2 
24 
1-7 
1-8 
1-9 
2-0 
2-1 
2-2 
2-3 
2-4 
2-5 
2-6 
2-7 
2-8 
2-9 
3-0 
3-1 
3-2 
3-3 
3-4 
3-5 
3-6 
3-7 
3-8 
3-9 
S 
S 
S 
D8 
S 
S 
D8 
D4 
Ds 
Da 
Da 
D8 
D3 
D3 
Da 
D8 
D3 
D3 
S 
All guinea pigs received 0.05 cc. of a 2 per cent virus suspension in each nostril. 
eight chemically treated guinea pigs and three untreated ones received pseudo- 
rabies virus intranasally along with the serum-treated animals. 
The  results  (Table  II)  confirm  the  observations  of  the  previous 
experiment, in that all the guinea pigs receiving virus 2 hours after ALBERT  B.  SABIlq  869 
the serum survived without showing any signs of disease, and demon- 
strate further that definite protection is evident at 5 hours, while an 
occasional  guinea  pig  may  perhaps  still  be  resistant  at  24  hours. 
All the animals which were treated either with 1 per cent tannic acid 
or  the  0.1  per  cent  neutral  acriflavine  died with  typical  signs  of 
pseudorabies, as did two of the three untreated ones. 
There are several points in this experiment which may be stressed. 
One, the relatively short duration of the protective action of nasally 
instilled  immune  serum,  may  be  accounted  for  by  the  probable 
washing out effect of the nasal secretions, which is in agreement with 
observations showing that in vitro minced, susceptible tissue, rendered 
refractory  to  infection by  exposure to  antiviral  serum,  may  again 
become  susceptible  after  repeated  washing  (5).  It  has  also  been 
recorded (11) that the testes from a rabbit actively immune to Virus 
III may, by washing, be rendered susceptible to  infection in vitro. 
The negative results with neutral acriflavine are of interest since it 
may mean that its action in the nose differs from that in the skin, or 
that its protective effect may be limited only to certain viruses, both 
possibilities being worthy of further study. 
Influence  of  Quantity  of  Serum  Administered.--When  0.5  cc.  of 
serum is instilled into each nostril of a guinea pig, possibly the greater 
portion of it is lost by sneezing or swallowing.  Yet, when half that 
amount of immune serum, i.e.,  0.25  co., was used in the preliminary 
experiments and the dose of virus was equally large, protection rarely 
followed.  In  view  of  the  results  of  the preceding experiments, it 
appeared possible that  this difficulty was due mainly to  the larger 
volume or amount of virus which either spread more easily beyond 
protected zones or persisted after the effect of the serum had worn 
off.  In the present test the effectiveness of the 0.25 and 0.5 cc. doses 
was compared in two groups of four guinea pigs (Table III).  The 
dose of virus, which was 0.05  co. of a  5 per cent suspension for each 
nostril, proved less infective than anticipated, since only two of the 
four controls developed the disease and died.  It is noteworthy, how- 
ever, that none of the serum-treated guinea pigs, which received this 
dose of virus 4  hours after the serum, showed any signs of disease. 
Attempts at Prolonging  the Duration of the Protective Effect of Nasally 
Instilled Immune  Serum.--Since  the relatively rapid loss of the re- 
fractory state induced by the nasal instillation of immune serum may 870  PROTECTIVE  ACTION  OF  SERUM  AGAINST  VIRUSES 
be attributable  to the fact that it is washed away by the nasal secre- 
tions,  several  attempts  were  made  to  determine  whether  certain 
agents may  help to retain  the serum in  the nose for a  longer time. 
In the first experiment, three parts of immune serum were mixed with one 
part respectively of saline, glycerol, or liquid paraffin, each mixture (0.5 cc. for 
each nostril) was given to a group of four guinea pigs, and the virus was adminis- 
tered 2 hours after treatment.  The results, shown  in Table IV, indicate that 
while glycerol and liquid paraffin did not inhibit the action of the serum, they 
exerted no appreciable effect, since all the guinea pigs treated with the serum- 
TABLE  III 
Relation between Quantity of Antipseudorabies Serum  Administered  Intranasally 
and Susceptibility to Infection 
Treatment 
Swine antlpseudorables serum  Guinea pig No.  Result 
0.25 cc. in each nostril 
0.5  "  "  "  " 
None--controls 
4-0 
4-1 
4-2 
4-3 
4-4 
4-5 
4-6 
4-7 
4-8 
4-9 
5-0 
5-1 
D4 
D8 
S 
S 
0.05  cc.  of  5  per cent  virus suspension in  each  nostril.  Interval between 
serum and virus--4 hours. 
saline mixture survived, while one of the four in each of the other two groups 
developed the disease and died.  Eight guinea pigs were treated with immune 
serum mixed with sufficient agar (about 0.66 per cent) to make a gelatinous mass 
and tested with virus 6 and 24 hours later, but they behaved as did the controls, 
all  succumbing  in  average  time.  Dried  serum  mixed  with  petrolatum  was 
totally ineffective.  Eight guinea pigs were treated with immune serum in the 
usual manner and within 20 to 30 minutes each was given 0.25 cc. of 0.66 per cent 
tannic acid per nostril to determine the possible effect of precipitating the serum 
in situ.  Virus was given 6 and 24 hours later.  No advantage over the ordinary 
serum-treated guinea pigs was secured (Table V). ALBERT  B.  SABIN  871 
Tests for Active Immunity in Protected Guinea Pigs.--Twelve guinea 
pigs  which,  as  a  result of the nasal instillation of immune  serum, 
proved to be refractory to a generally lethal test dose of pseudorabies 
virus, were retested with the same dose and by the same route 10 to 
15  days later to  determine whether or not they had acquired any 
TABLE  IV 
Effect of Mixing Glycerol or Liquid Para~n with  Immune Serum on Its Protective 
Action in the Nose 
Treatment  Amount of .1%. 
(0.5 cc. in each nostril)  virus suspension  m  Guinea  pig No.  Result 
each nostril 
None 
Immune serum--3 parts 
+ 
Saline--I part 
Immune serum--3 parts 
+ 
Liquid paraffan--1 part 
Immune serum--3 parts 
+ 
Glycerol--1 part 
CC. 
0.025 
0.05 
0.05 
0.05 
0.05 
5-2 
5-3 
5-4 
5-5 
5-6 
5-7 
5-8 
5-9 
6-0 
6-1 
6-2 
6-3 
6-4 
6-5 
6-6 
6-7 
6-8 
6-9 
S 
S 
S 
D4 
D4 
Ds 
D3 
S 
s 
s 
S 
S 
S 
Da 
Virus given 2 hours after treatment. 
active  immunity.  As  all  of  them  developed  typical pseudorabies 
and died, it could be assumed  that the primary treatment had pro- 
tected them completely from the effects of the virus so that no active 
immunity ensued. 
Experiments with Mice and Equine Encephalomyelitis Virus (Eastern 
Strain).--The purpose of the following experiments was to determine TABLE  V 
Attempted Prolongation of Protective Effect of A ntipseudorabies Serum in Nose by 
Combination witk Various Agents 
Experiment 
1I 
Treatment 
Antipseudorabies 
swine serum alone 
Immune  serum  in 
agar jelly 
Dry  immune  serum 
in petrolatum 
None 
Immune  serum  in 
agar jelly 
Immune  serum  fol- 
lowed  in  20  min. 
by  0.66%  tannic 
add 
None 
Interval between 
treatment and 
virus 
]$r$, 
6 
24 
24 
Guinea pig No. 
7-0 
7-1 
7-2 
7-3 
7-4 
7-5 
7-6 
7-7 
7-8 
7-9 
8-0 
8-1 
8-2 
8-3 
8-4 
8-5 
8-6 
8-7 
8-8 
8-9 
9-0 
9-1 
9-2 
9-3 
9-4 
9-5 
9-5 
9-7 
9-8 
9-9 
1-00 
1-01 
1-02 
1-03 
1-04 
1-05 
Result 
S 
S 
Da 
D3 
S 
S 
S 
D5 
D3 
D4 
Da 
Da 
D3 
D4 
D4 
S 
S 
D3 
D8 
Da 
S 
S 
D3 
D8 
S 
S 
D~ 
D4 
S 
D8 
Ds 
D5 
D2 
D8 
Da 
Da 
0.05 cc. of a  2 per cent virus suspension in each nostril. 
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whether the phenomenon of local immune serum protection against 
infection by the nasal route occurred with another virus and in  an- 
other  host. 
TABLE VI 
Effect  of Nasal  Instillation  of Immune  Serum  on  the  Susceptibility  of Mice  to 
Infection with Eastern Equine Encephalomyelitis  Virus by the Nasal Route 
Experiment 
Virus suspension in 
broth 
II 
Virus suspension in 
broth 
III 
Virus suspension in 
saline 
Interval  Amount of virus 
Treatment  between  No. of  BTo. 
i (0.05 cc. intranasally)  serum  mice  sur- 
and  used  vive¢  virus  cc.  Dilution 
hrs. 
Immune serum  2  O. 02  1:200  6  6 
4  "  "  6  4 
None 
Immune serum  2.5 
4 
Normal  serum 
None 
Immune serum 
Normal serum 
None 
"  "  3  0 
"  1:1,000  3  0 
"  1:10,000  3  0 
"  1:100,000  3  2 
"  1:1,000,000  3  3 
0.03  1:200  6  1 
"  "  6  1 
2.5  "  "  6  0 
--  "  "  6  0 
"  1:1,000  3  0 
"  I: 10,000  3  1 
2.5  0.02  1:200  6  5 
2.5  0.03  "  6  4 
2.5  0.02  " 
"  1:1,000 
"  1:10,000 
Eastern equine encephalomyelitis  virus given to mice intranasally  produces a 
fatal encephalomyelitis  in 3 to 5 days.  Twelve mice were each given 0.05 cc. of 
rabbit hyperimmune serum by placing drops of the serum on their nasal orifices 
and allowing them to aspirate.  The test dose of virus was 0.02 cc.  (similarly 
administered) of a 1:200 dilution of centrifuged fresh mouse brain suspension in 
broth.  Since this virus can produce encephalitis by routes other than the nasal, 874  PROTECTIVE  ACTION  OF  SERUM  AGAINST  VIRUSES 
the test dose was only 0.02 cc. in order to prevent as far as possible  its being 
aspirated into the lungs.  One group of six mice received the virus 2 hours after 
treatment and the other group after an interval of 4 hours.  The infectivity of 
the virus suspension  by the nasal route was simultaneously titrated on mice of 
similar age.  As shown in Table VI, while all the control mice which received 
0.02 cc. of the 1:200, l:l,000, and 1:10,000  dilutions of the virus, and one of 
three of the 1 : 100,000 group developed a fatal encephalitis, none of the six mice 
treated 2 hours before receiving virus showed any signs of disease  and only two 
of the six mice treated 4 hours before infection developed encephalitis.  The ten 
protected, surviving mice were tested for active immunity 18 days later and all 
succumbed, indicating, as in the case of pseudorabies, the lack of an active im- 
munity. 
A suspension of the virus in broth has been found to be considerably more 
encephalitogenic in mice than one in saline, and when 0.03 cc. instead of 0.02 cc. 
of virus suspension in broth was used as the nasal test dose, protection rarely 
occurred (Experiment II, Table VI, and others).  With saline suspensions  of 
virus, protection was shown with both doses.  It should also be stated that while 
in the case of pseudorabies the intramuscular injection of 3 cc. of immune serum 
to guinea pigs weighing about 300 gin., or the equivalent of l0 cc. per kilo, failed 
to protect them against nasal infection with a dose in the minimal effective range, 
four 20 gin. mice, each receiving 1 cc. of immune serum intraperitoneally, or the 
equivalent of 50 cc. per kilo, 4 hours before infection, were protected against a 
lethal amount of equine encephalomyelitis virus given by the nasal route. 
From  these  experiments  it  appears  that  while  passive  systemic 
immunity  against  nasal  infection,  that  is,  against  invasion of virus 
by the nasal route, is not an impossibility, it is nevertheless difficult 
to achieve probably because of the relatively large amount of antibody 
required in larger hosts. 
DISCUSSION 
The purpose of this communication is to present evidence that the 
nasal  mucosa and  the nerve endings in  it may be protected tempo- 
rarily from infection with certain viruses by a preliminary flushing or 
spraying of these  tissues  with immune  serum,  and  that  when  these 
primary receptor cells for the virus are so blocked or protected, the 
virus does not invade the rest of the organism and disease does not 
ensue.  That the action of the immune serum thus introduced in the 
nose is  a  local one is  apparent  from an  experiment in  which larger 
amounts of the same serum given systemically failed, in  the case of 
pseudorabies  virus,  to  protect  guinea  pigs  against  infection  by  the ALBERT B.  SABIN  875 
nasal route.  If,  as is generally assumed, the virus comes in direct 
contact with nervous elements in the nose, the phenomenon  of specific 
local protection in this region is particularly noteworthy in the case 
of pseudorabies in the guinea pig, since the immune serum is prac- 
tically devoid of any antiviral action when introduced with the virus 
directly into the brain, and it would appear,  therefore, that in this 
instance, at least, the capacity or mode of protection may be differ- 
ent in peripheral and central nervous tissues.  The subject is obvi- 
ously one calling for further study. 
The protective effect of immune serum in the nose begins immedi- 
ately after instillation, is still evident 5  hours later,  and usually is 
entirely dissipated by the end of 24 hours.  Attempts to prolong its 
effect by incorporating with the serum substances such as glycerol, 
liquid paraffin, semisolid agar, petrolatum, and by precipitating the 
serum in situ with tannic acid proved unsuccessful. 
SUMMARY 
i. Immune  serum  instilled  intranasally in guinea pigs has pro- 
tected them from infection with lethal amounts of pseudorabies virus 
by  the nasal  route.  The  same  effect was  obtained  in  mice  with 
immune serum against the virus of equine encephalomyelitis (Eastern 
strain). 
2.  The protective effect of the immune serum in the nose begins 
at the time of instillation, is still evident 5 hours later,  and usually 
has disappeared by the end of 24 hours. 
3.  Attempts to  prolong the local effectiveness of immune serum 
by means of several devices were unsuccessful. 
4.  The action of the immune serum appears to be a  local one in 
the nose, in view of the fact that the administration of even larger 
amounts of it intramuscularly failed to protect guinea pigs against 
infection with pseudorabies by the nasal route. 
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